"Pharmax Research of South Florida, Inc. is a multi-specialty research facility specializes in conducting Phase II, III and IV Clinical Trials. We have a highly trained, certified and dedicated medical research staff that provide exceptional research services and adhere to the highest standards of clinical research."

During the past decade, Pharmax Research of South Florida, Inc conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pharmax Research of South Florida, Inc" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials, followed by "Eisai Inc." with 1 trials sponsored, "Enterin Inc." with 1 trials sponsored, "Evofem Inc." with 1 trials sponsored and "Integrative Research Laboratories AB" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pharmax Research of South Florida, Inc" #1 collaborator was "Biogen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pharmax Research of South Florida, Inc" are "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Parkinson Disease" (2 trials), "Chlamydia" (1 trials), "Constipation" (1 trials) and "Early Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Pharmax Research of South Florida, Inc" in a lesser frequency.

Most popular intervention types in "Pharmax Research of South Florida, Inc" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AVP-786" (2 trials), "Active Investigational Treatment ENT-01" (1 trials), "EVO100" (1 trials) and "Lecanemab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pharmax Research of South Florida, Inc" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pharmax Research of South Florida, Inc". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pharmax Research of South Florida, Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pharmax Research of South Florida, Inc, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".